Journal of Biological Chemistry,
Journal Year:
2024,
Volume and Issue:
300(12), P. 107999 - 107999
Published: Nov. 15, 2024
TAR
DNA-binding
protein
43
(TDP-43)
is
a
DNA/RNA
binding
predominantly
localized
in
the
nucleus
under
physiological
conditions.
TDP-43
proteinopathy,
characterized
by
cytoplasmic
aggregation
and
nuclear
loss,
associated
with
many
neurodegenerative
diseases,
including
amyotrophic
lateral
sclerosis
(ALS)
frontotemporal
lobar
degeneration
(FTLD).
Thus
it
crucial
to
understand
molecular
mechanism
regulating
homeostasis.
Here,
we
show
that
uptake
of
oligodeoxynucleotides
(ODNs)
from
extracellular
space
induces
reversible
puncta
formation
both
neurons
glia.
ODNs
facilitate
liquid-liquid
phase
separation
vitro.
Importantly,
persistent
accumulation
DNA
cytoplasm
leads
depletion
enhanced
production
short
isoform
(sTDP-43).
In
addition,
response
ODN
uptake,
import
receptor
karyopherin
subunit
β1
(KPNB1)
sequestered
cytosolic
puncta.
ALS-linked
Q331K
mutation
decreases
dynamics
increases
levels
sTDP-43.
Moreover,
are
induced
damage
impaired
envelope
integrity
due
Lamin
A/C
deficiency.
summary,
our
data
support
abnormal
may
be
one
key
mechanisms
leading
proteinopathy
provides
novel
insights
into
ALS
caused
mutations.
Muscle & Nerve,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 19, 2025
ABSTRACT
Introduction/Aims
Akt
intracellular
signal
transduction
pathway
dysfunction
has
been
reported
in
people
with
amyotrophic
lateral
sclerosis
(ALS)
providing
a
novel
target
for
intervention
this
devastating
progressive
disease.
This
first‐in‐human
study
evaluated
the
safety,
tolerability,
and
preliminary
efficacy
of
activator,
IPL344,
ALS.
Methods
Nine
participants
ALS
progression
rate
>
0.55
points/month
on
Amyotrophic
Lateral
Sclerosis
Functional
Rating
Scale
(ALSFRS‐R)
received
open‐label
IPL344
treatment
(once‐daily)
up
to
36
months.
Safety
was
assessed
through
adverse
event
(AE)
reporting.
Plasma
neurofilament
light
chain
(NfL)
concentrations
were
measured
before
after
treatment.
Clinical
outcomes
compared
historical
data.
Results
The
mean
±
SD
duration
follow‐up
14.0
12.5
One
participant
developed
drug
hypersensitivity,
two
had
central
venous
catheter‐related
AEs,
serious
pneumonia
AEs.
unadjusted
SE
slope
decline
ALSFRS‐R
−0.53
0.15
(48%
slower
vs.
controls,
p
=
0.028).
Adjustment
disease
stage
rate‐indicating
covariates
indicated
64%
(
0.034),
increased
rather
than
reduced
body
weight
0.02).
Eight
nine
IPL344‐treated
significantly
improved
median
matched
control
group
0.04).
NfL
lowered
by
27%
n
6).
Unadjusted
survival
43.4
months
[95%
CI:
20.5,
NA]
19.1
[17.4,
23.0]
group.
Discussion
These
data
indicate
that
safe
well‐tolerated,
possibly
effective.
Our
findings
may
merit
further
investigation
larger
placebo‐controlled
clinical
trial.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,
Journal Year:
2024,
Volume and Issue:
1870(5), P. 167192 - 167192
Published: April 22, 2024
Several
mutations
in
the
SOD1
gene
encoding
for
antioxidant
enzyme
Superoxide
Dismutase
1,
are
associated
with
amyotrophic
lateral
sclerosis,
a
rare
and
devastating
disease
characterized
by
motor
neuron
degeneration
patients'
death
within
2–5
years
from
diagnosis.
Motor
loss
related
symptomatology
manifest
mostly
adult
life
and,
to
date,
there
is
still
gap
of
knowledge
on
precise
cellular
molecular
events
preceding
neurodegeneration.
To
deepen
our
awareness
early
phases
disease,
we
leveraged
two
Drosophila
melanogaster
models
pan-neuronally
expressing
either
mutation
A4V
or
G85R
human
(hSOD1A4V
hSOD1G85R).
We
demonstrate
that
pan-neuronal
expression
hSOD1A4V
hSOD1G85R
pathogenic
construct
impairs
survival
performance
transgenic
flies.
Moreover,
protein
transcript
analysis
fly
heads
indicates
mutant
hSOD1
induction
stimulates
glial
marker
Repo,
up-regulates
IMD/Toll
immune
pathways
through
antimicrobial
peptides
interferes
oxidative
metabolism.
Finally,
cytological
larval
brains
demonstrates
hSOD1-induced
chromosome
aberrations.
Of
note,
these
parameters
found
modulated
timeframe
when
neurodegeneration
not
detected.
The
novelty
work
twofold:
have
expressed
first
time
all
neurons
confirmed
some
ALS-related
pathological
phenotypes
flies,
confirming
power
generating
ALS-like
phenotypes.
pathogenesis
aberrations
up-regulation.
These
findings
were
unexplored
SOD1-ALS
field.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Oct. 7, 2024
Aging
is
characterized
by
the
accumulation
of
proteins
that
display
amyloid-like
behavior.
However,
molecular
mechanisms
which
these
arise
remain
unclear.
Here,
we
demonstrate
are
produced
in
a
variety
human
cell
types,
including
stem
cells,
brain
organoids
and
fully
differentiated
neurons
mistakes
occur
messenger
RNA
molecules.
Some
generate
mutant
already
known
to
cause
disease,
while
others
have
not
been
observed
before.
Moreover,
show
increase
when
cells
exposed
DNA
damage,
major
hallmark
aging.
When
taken
together,
experiments
suggest
mechanistic
link
between
normal
aging
process
age-related
diseases.
Cells,
Journal Year:
2024,
Volume and Issue:
13(11), P. 928 - 928
Published: May 28, 2024
Amyotrophic
Lateral
Sclerosis
(ALS)
is
a
group
of
sporadic
and
genetic
neurodegenerative
disorders
that
result
in
losses
upper
lower
motor
neurons.
Treatment
ALS
limited,
survival
2–5
years
after
disease
onset.
While
can
occur
younger
individuals,
the
risk
significantly
increases
with
advancing
age.
Notably,
both
forms
share
pathophysiological
features
overlapping
hallmarks
aging
including
genome
instability/DNA
damage,
mitochondrial
dysfunction,
inflammation,
proteostasis,
cellular
senescence.
This
review
explores
chronological
biological
context
onset
progression.
Age-related
muscle
weakness
unit
loss
mirror
aspects
pathology
coincide
peak
incidence,
suggesting
potential
link
between
development.
Hallmarks
aging,
DNA
senescence,
are
implicated
ALS,
offering
insights
into
shared
mechanisms
underlying
pathogenesis.
Furthermore,
senescence-associated
secretory
phenotype
senolytic
treatments
emerge
as
promising
avenues
for
intervention,
to
mitigate
neuroinflammation
modify
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(14), P. 7906 - 7906
Published: July 19, 2024
Neurons
in
the
brain
are
continuously
exposed
to
various
sources
of
DNA
damage.
Although
mechanisms
damage
repair
mitotic
cells
have
been
extensively
characterized,
pathways
post-mitotic
neurons
still
largely
elusive.
Moreover,
inaccurate
can
result
deleterious
mutations,
including
deletions,
insertions,
and
chromosomal
translocations,
ultimately
compromising
genomic
stability.
Since
terminally
differentiated
cells,
they
cannot
employ
homologous
recombination
(HR)
for
double-strand
break
(DSB)
repair,
suggesting
existence
neuron-specific
mechanisms.
Our
research
has
centered
on
microtubule-associated
protein
tau
(MAPT),
a
crucial
pathological
implicated
neurodegenerative
diseases,
its
interplay
with
neurons'
response
(DDR).
This
review
aims
provide
an
updated
synthesis
current
understanding
complex
between
DDR
cytoskeletal
proteins
neurons,
particular
focus
role
disorders.
iScience,
Journal Year:
2023,
Volume and Issue:
26(9), P. 107505 - 107505
Published: July 28, 2023
The
ALS/FTD-linked
intronic
hexanucleotide
repeat
expansion
in
the
C9orf72
gene
is
aberrantly
translated
sense
and
antisense
directions
into
dipeptide
proteins,
among
which
poly
proline-arginine
(PR)
displays
most
aggressive
neurotoxicity
in-vitro
in-vivo.
PR
partitions
to
nucleus
when
heterologously
expressed
neurons
other
cell
types.
We
show
that
by
lessening
nuclear
accumulation
of
PR,
we
can
drastically
reduce
its
neurotoxicity.
strongly
accumulates
nucleolus,
a
structure
critical
regulating
stress
response.
determined
that,
neurons,
caused
nucleolar
increased
levels
transcription
factor
p53.
Downregulating
p53
also
prevented
PR-mediated
both
in-vivo
models.
investigated
if
could
induce
senescence
phenotype
neurons.
However,
did
not
observe
any
indications
such
an
effect.
Instead,
found
evidence
for
induction
programmed
death
via
caspase-3
activation.
Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: Oct. 2, 2023
A
common
pathological
hallmark
of
amyotrophic
lateral
sclerosis
(ALS)
and
frontotemporal
dementia
(FTD)
is
the
cytoplasmic
mislocalization
aggregation
DNA/RNA-binding
protein
TDP-43,
but
how
loss
nuclear
TDP-43
function
contributes
to
ALS
FTD
pathogenesis
remains
largely
unknown.
Here,
using
large-scale
RNAi
screening,
we
identify
TARDBP
,
which
encodes
as
a
gene
whose
loss-of-function
results
in
elevated
DNA
mutation
rate
genomic
instability.
Consistent
with
this
finding,
observe
increased
damage
induced
pluripotent
stem
cells
(iPSCs)
iPSC-derived
post-mitotic
neurons
generated
from
patients
harboring
mutations.
We
find
that
increase
due
defects
two
major
pathways
for
double-strand
break
repair:
non-homologous
end
joining
homologous
recombination.
Cells
repair
are
sensitive
damaging
agents
and,
accordingly,
show
marked
reduction
survival
following
treatment
agent.
Importantly,
also
observed
depletion
ALS/FTD
patient
brain
tissues.
Collectively,
our
demonstrate
have
levels
contribute
idea
instability
defining
feature
pathology.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Feb. 16, 2023
The
ALS/FTD-linked
intronic
hexanucleotide
repeat
expansion
in
the
C9orf72
gene
is
translated
into
dipeptide
proteins,
among
which
poly-proline-arginine
(PR)
displays
most
aggressive
neurotoxicity
in-vitro
and
in-vivo
.
PR
partitions
to
nucleus
when
expressed
neurons
other
cell
types.
Using
drosophila
primary
rat
cortical
as
model
systems,
we
show
that
by
lessening
nuclear
accumulation
of
PR,
can
drastically
reduce
its
neurotoxicity.
accumulates
nucleolus,
a
site
ribosome
biogenesis
regulates
stress
response.
We
examined
effect
nucleolar
impact
on
function
determined
caused
increased
levels
transcription
factor
p53.
Downregulating
p53
levels,
either
genetically
or
increasing
degradation,
also
prevented
PR-mediated
neurotoxic
phenotypes
both
models.
investigated
whether
could
cause
senescence
phenotype
but
observed
none.
Instead,
found
induction
apoptosis
via
caspase-3
activation.
In
summary,
uncovered
central
role
dysfunction
upon
expression
context
C9-ALS/FTD.